Related references
Note: Only part of the references are listed.Mutant Prevention Concentration (MPC) of Ciprofloxacin Against Salmonella enterica of Epidemic and Poultry Origin
Rafaela Ferrari et al.
CURRENT MICROBIOLOGY (2011)
TolC dependency of multidrug efflux systems in Salmonella enterica serovar Typhimurium
Tsukasa Horiyama et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli
Nick G. Coldham et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Experimental identification and characterization of 97 novel npcRNA candidates in Salmonella enterica serovar Typhi
Suresh V. Chinni et al.
NUCLEIC ACIDS RESEARCH (2010)
Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium
Jie Zheng et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Only for substrate antibiotics are a functional AcrAB-TolC efflux pump and RamA required to select multidrug-resistant Salmonella Typhimurium
Vito Ricci et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Decreased fluoroquinolone susceptibility in mutants of Salmonella serovars other than Typhimurium: detection of novel mutations involved in modulated expression of ramA and soxS
Corinna Kehrenberg et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium
Yousef M. Abouzeed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine
Andrew M. Bailey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
AcrAB multidrug efflux pump regulation in Salmonella enterica serovar typhimurium by RamA in response to environmental signals
Eiji Nikaido et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations
Corinna Kehrenberg et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Mutant selection window hypothesis updated
Karl Drlica et al.
CLINICAL INFECTIOUS DISEASES (2007)
The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets
Arthur K. Turner et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism
Markus A. Seeger et al.
SCIENCE (2006)
Multidrug resistance pump AcrAB-TolC is required for high-level, Tet(A)-mediated tetracycline resistance in Escherichia coli
Ricardo E. de Cristobal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Resistance to fluoroquinolones in Salmonella:: emerging mechanisms and resistance prevention strategies
Etienne Giraud et al.
MICROBES AND INFECTION (2006)
Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa
GT Hansen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs
SE Cosgrove
CLINICAL INFECTIOUS DISEASES (2006)
Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium
K Nishino et al.
MOLECULAR MICROBIOLOGY (2006)
Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC
V Ricci et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Mechanisms of quinolone resistance in Escherichia coli and Salmonella:: Recent developments
KL Hopkins et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States
AC Voetsch et al.
CLINICAL INFECTIOUS DISEASES (2004)
Expression of acrB, acrF, acrD, marA, and soxS in salmonella enterica serovar typhimurium:: Role in multiple antibiotic resistance
DJ Eaves et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Mutant prevention concentration:: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis
JC Rodríguez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Salmonella enterica serovar typhimurium RamA, intracellular oxidative stress response, and bacterial virulence
T van der Straaten et al.
INFECTION AND IMMUNITY (2004)
Mutant prevention concentration of nalidixic acid, ciprofloxacin, clinafloxacin, levofloxacin, norfloxacin, ofloxacin, sparfloxacin or trovafloxacin for Escherichia coli under different growth conditions
HJ Linde et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Mutant prevention concentrations of ciprofloxacin and enrofloxacin for Salmonella enterica
LP Randall et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Antibacterial resistance worldwide: causes, challenges and responses
SB Levy et al.
NATURE MEDICINE (2004)
Salmonella gene rma (ramA) and multiple-drug-resistant Salmonella enterica serovar Typhimurium
T van der Straaten et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
The importance of active efflux systems in the quinolone resistance of clinical isolates of Salmonella spp.
I Escribano et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium DT104
S Baucheron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
The mutant selection window and antimicrobial resistance
K Drlica
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump
EW Yu et al.
SCIENCE (2003)
Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection
J Ruiz
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli
S Yang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Mutant prevention concentration of gemifloxacin for clinical isolates of Streptococcus pneumoniae
GT Hansen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Emerging mechanisms of fluoroquinolone resistance
DC Hooper
EMERGING INFECTIOUS DISEASES (2001)
A soxRS-constitutive mutation contributing to antibiotic resistance in a clinical isolate of Salmonella enterica (serovar Typhimurium)
A Koutsolioutsou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
NorM of Vibrio parahaemolyticus is an Na+-driven multidrug efflux pump
Y Morita et al.
JOURNAL OF BACTERIOLOGY (2000)
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
KA Datsenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance
A Lee et al.
JOURNAL OF BACTERIOLOGY (2000)
Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium
E Giraud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
